# BYDUREON BCISE
> **NDA209210** · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2017-10-20
## Drug
- **FDA Application Number:** NDA209210
- **Application type:** New Drug Application
- **Brand name:** BYDUREON BCISE
- **Generic name:** Exenatide Synthetic
- **Active ingredients:** EXENATIDE SYNTHETIC
- **Dosage form:** SUSPENSION, EXTENDED RELEASE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** ASTRAZENECA AB
- **First approval:** 2017-10-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209210)
---
*MORVS · CC0 1.0*